Fengji Xu

1.3k total citations
17 papers, 1.0k citations indexed

About

Fengji Xu is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Fengji Xu has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Reproductive Medicine and 7 papers in Oncology. Recurrent topics in Fengji Xu's work include Ovarian cancer diagnosis and treatment (8 papers), Epigenetics and DNA Methylation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Fengji Xu is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Epigenetics and DNA Methylation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Fengji Xu collaborates with scholars based in United States, United Kingdom and Australia. Fengji Xu's co-authors include Robert C. Bast, Yinhua Yu, Hongqi Peng, Xianjun Fang, Gordon B. Mills, Joe W. Gray, Ian Jacobs, Andrew Berchuck, Nina Einhorn and Yuchiao Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and Oncogene.

In The Last Decade

Fengji Xu

16 papers receiving 1.0k citations

Peers

Countries citing papers authored by Fengji Xu

Since Specialization

Citations

This map shows the geographic impact of Fengji Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengji Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengji Xu more than expected).

Fields of papers citing papers by Fengji Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengji Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengji Xu. The network helps show where Fengji Xu may publish in the future.

Co-authorship network of co-authors of Fengji Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengji Xu. A scholar is included among the top collaborators of Fengji Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengji Xu. Fengji Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Additive and Synergistic Interactions of Monoclonal Antibodies and Immunotoxins Reactive with Breast and Ovarian Cancer 2020 ·PubMed ·Robert C. Bast, Fengji Xu, Yinhua Yu, Jennie R. Crews, Yair Argon, (unknown), (unknown), Cinda M. Boyer	0
2	Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer 2007 ·Gynecologic Oncology ·Zhen Zhang, Yinhua Yu, Fengji Xu, Andrew Berchuck, (unknown), Laura J. Havrilesky, H.W.A. de Bruijn, Ate G.J. van der Zee, Robert Woolas, Ian Jacobs, Steven J. Skates, Daniel W. Chan, Robert C. Bast	80
3	OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma 2001 ·Cancer ·(unknown), Yu Shen, Fengji Xu, Yinhua Yu, A. Berchuck, Laura J. Havrilesky, H.W.A. de Bruijn, Ate G.J. van der Zee, Robert C. Bast, Neville F. Hacker	87
4	Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI 2001 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Robert Z. Luo, Hongqi Peng, Fengji Xu, Jiaju Bao, Yong Pang, (unknown), Jean‐Pierre J. Issa, Warren S.‐L. Liao, Robert C. Bast, Yinhua Yu	34
5	ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers 2000 ·International Journal of Cancer ·Hongqi Peng, Fengji Xu, (unknown), Kelly K. Hunt, Marsha L. Frazier, A. Berchuck, Joe W. Gray, David Hogg, Robert C. Bast, Yinhua Yu	50
6	Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass 2000 ·International Journal of Cancer ·Estrid Høgdall, Claus Høgdall, Solveig Tingulstad, Bjørn Hagen, Kjell Nustad, Fengji Xu, Robert C. Bast, Ian Jacobs	25
7	Combination of Multiple Serum Markers Using an Artificial Neural Network to Improve Specificity in Discriminating Malignant from Benign Pelvic Masses 1999 ·Gynecologic Oncology ·Zhen Zhang, (unknown), Hong Zhang, Fengji Xu, Yinhua Yu, Ian Jacobs, Robert Woolas, Andrew Berchuck, (unknown), Robert C. Bast	65
8	OVX1 Radioimmunoassay Results Are Dependent on the Method of Sample Collection and Storage 1999 ·Clinical Chemistry ·Estrid Høgdall, Claus Høgdall, Susanne K. Kjær, Fengji Xu, Yinhua Yu, Robert C. Bast, Jan Blaakær, Ian Jacobs	13
9	NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas 1999 ·Proceedings of the National Academy of Sciences ·Yinhua Yu, Fengji Xu, Hongqi Peng, Xianjun Fang, Shulei Zhao, Yang Li, Bruce D. Cuevas, Wen-Lin Kuo, Joe W. Gray, Michael J. Siciliano, Gordon B. Mills, Robert C. Bast	243
10	Suppression of Diacylglycerol Levels by Antibodies Reactive with the c-erbB-2 (HER-2/neu) Gene Product p185c-erbB-2in Breast and Ovarian Cancer Cell Lines 1998 ·Gynecologic Oncology ·Matthew Boente, Andrew Berchuck, Regina S. Whitaker, Anders Kalén, Fengji Xu, Daniel L. Clarke‐Pearson, Robert M. Bell, Robert C. Bast	4
11	Expression of p16 induces transcriptional downregulation of the RB gene 1998 ·Oncogene ·Xianjun Fang, Xiaomei Jin, Hong-Ji Xu, Lin Liu, (unknown), David Hogg, Jack A. Roth, Yinhua Yu, Fengji Xu, Robert C. Bast, Gordon B. Mills	72
12	Is OVX1 a Suitable Marker for Endometrial Cancer? 1997 ·Gynecologic Oncology ·(unknown), (unknown), (unknown), Fengji Xu, Robert C. Bast, (unknown)	23
13	Combinations of Multiple Serum Markers Are Superior to Individual Assays for Discriminating Malignant from Benign Pelvic Masses 1995 ·Gynecologic Oncology ·Robert Woolas, Mark R. Conaway, Fengji Xu, Ian Jacobs, Yinhua Yu, L. Daly, Ann Prys Davies, Kathy O'Briant, Andrew Berchuck, John T. Soper, Daniel L. Clarke‐Pearson, Gustavo Rodríguez, David Oram, Robert C. Bast	90
14	Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers 1995 ·Cancer ·(unknown), Fengji Xu, Yinhua Yu, K. Sjövall, Nina Einhorn, Yuchiao Chang, Robert C. Bast, (unknown)	174
15	OVX1 as a marker for early stage endometrial carcinoma 1994 ·Cancer ·Fengji Xu, Yinhua Yu, L. Daly, (unknown), G. Michael Hass, Andrew Berchuck, Gustavo C. Rodriguez, John T. Soper, Daniel L. Clarke‐Pearson, Donna Hollis, Cinda M. Boyer, Robert C. Bast	9
16	Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185 1993 ·International Journal of Cancer ·Fengji Xu, Ruth Lupu, Gustavo C. Rodriguez, Regina S. Whitaker, Matthew Boente, Andrew Berchuck, Yinhua Yu, K DeSombre, Cinda M. Boyer, Robert C. Bast	53
17	The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines 1993 ·American Journal of Obstetrics and Gynecology ·Gustavo C. Rodriguez, Matthew Boente, Andrew Berchuck, Regina S. Whitaker, Kathy O'Briant, Fengji Xu, Robert C. Bast	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact